logo inner

Scientist I/II

CareDxBrisbane, Australia | California, United StatesOnsite

CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
We are seeking a motivated and innovative Scientist I/Scientist II to join our dynamic R&D team. In this role, you will contribute to the development of cutting-edge diagnostic solutions, leveraging your expertise to drive assay development and validation projects. Collaboration is key, as you will interface with cross-functional teams, including bioinformatics, biostatistics, data science, clinical operations, and regulatory affairs. Proficiency in molecular biology methods for nucleic acid characterization and related applications is essential, along with a critical and creative approach to problem-solving. 

Responsibilities: 


  • Initiate, design, and execute experiments to develop and/or improve high-value diagnostic tests
  • Use molecular biology approaches to independently develop and optimize molecular diagnostics assays
  • Perform basic analysis of high-dimensional data and collaborate with statistics and bioinformatics teams for comprehensive data interpretation.
  • Provide expert support and guidance regarding experiment design, data analysis, and results to the broader scientific team
  • Collaborate across multiple departments to ensure seamless integration of scientific insights into broader research goals
  • Design, initiate, and execute experiments to develop or enhance high-value diagnostic tests.

Qualifications: 


  • Ph.D. in genomics, molecular biology, or a related field with 0–2 years of relevant experience (Scientist I) or 2–5 years (Scientist II). Candidates with a BS or MS and significant experience may also be considered. Industry experience developing diagnostic assays is preferred.
  • Solid foundation in molecular biology, with hands-on experience in NGS library preparation and Illumina sequencing platforms. Familiarity with methylation sequencing library preparation is a plus.
  • Expertise in nucleic acid and cell-free DNA extraction techniques.
  • Strong interdisciplinary communication skills to foster collaboration and effective knowledge exchange.
  • Excellent organizational skills with acute attention to detail, ensuring high-quality outputs in a fast-paced environment.

Additional Details:


Every individual at CareDx has a direct impact on our collective mission to improve the lives of organ transplant patients worldwide. We believe in taking great care of our people, so they take even greater care of our patients.Our competitive Total Rewards package includes:

  • Competitive base salary and incentive compensation
  • Health and welfare benefits including a gym reimbursement program
  • 401(k) savings plan match
  • Employee Stock Purchase Plan
  • Pre-tax commuter benefits
  • And more!

In addition, we have a Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.With products that are making a difference in the lives of transplant patients today and a promising pipeline for the future, it’s an exciting time to be part of the CareDx team. Join us in partnering with transplant patients to transform our future together.

CareDx, Inc. is an Equal Opportunity Employer and participates in the E-Verify program.


By proceeding with our application and submitting your information, you acknowledge that you have read our 


U.S. Personnel Privacy Notice


and consent to receive email communication from CareDx.


******** We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.#LI-Onsite

Life at CareDx

CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. http://www.allosure.com/ About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients. http://www.allomap.com/
Thrive Here & What We Value1. Focus on improving the lives of organ transplant patients worldwide2. Taking great care of our people, so they take even greater care of our patients3. CareDx offers products, testing services, and digital healthcare solutions along the pre and post-transplant patient journey4. CareDx is the leading provider of genomics-based information for transplant patients5. Competitive Total Rewards package including: Competitive base salary and incentive compensation, Health and welfayer benefits, 401(k) savings plan match, Employee Stock Purchase Plan, Pretax commuter benefits
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2025